Roche is committed to providing innovative solutions for treatment and diagnostic tests for the management of respiratory viral infections.
During flu season, reliable diagnostic solutions can help differentiate between the SARS-CoV-2 and influenza A/B viruses so that healthcare providers can make informed decisions on which treatments are appropriate, help improve patient outcomes, and return to a normal life.
Influenza and COVID-19 are respiratory illnesses that are caused by different viruses. COVID-19 along with emerging variants, results from the novel coronavirus, known as SARS-CoV-2, while the flu is caused by influenza viruses.1 Both viruses spread between people in close contact through droplets that come from coughing, sneezing, talking, or sharing eating utensils or drinks. Each can be transmitted between individuals even before symptoms are noticeable and People can experience a range of symptoms -- from no symptoms (asymptomatic) to severe symptoms.